Abstract. In the present study, laboratory techniques were used to diagnose canine G M2 -gangliosidosis using blood and cerebrospinal fluid (CSF) that can be collected noninvasively from living individuals. Lysosomal acid ␤-hexosaminidase (Hex) was measured spectrofluorometrically using 4-methylumbelliferyl N-acetyl-␤-Dglucosaminide and 4-methylumbelliferyl 7-(6-sulfo-2-acetamido-2-deoxy-␤-D-glucopyranoside) as substrates. Main isoenzymes A and B of Hex in leukocytes were also analyzed using cellulose acetate membrane electrophoresis. G M2 -ganglioside in CSF was detected and determined quantitatively by using thin-layer chromatography/enzyme-immunostaining method with anti
Lysosomal diseases are a group of genetic disorders of cellular metabolism caused by a deficiency of certain catabolic reaction(s) within the lysosomal catabolic pathway. 11, 26, 30 In humans, more than 40 genetically determined lysosomal disorders have been described, whereas in animals, only 30 disorders have been documented and reported.
G M2 -gangliosidoses are a rare group of lysosomal diseases caused by excessive accumulation of G M2 -ganglioside and related glycolipids in lysosomes, especially in the lysosomes of neurons, and are manifested as progressive neurological disorders involving motor and psychointellectual dysfunctions, visual defects, and so on. 10, 19 The hydrolysis of G M2 -ganglioside is catalyzed by lysosomal ␤-hexosaminidase (Hex), but this hydrolysis requires that it be complexed with a substrate-specific cofactor, the G M2 activator protein.
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the ␣-subunits of Hex A and Hex S; HEXB, which encodes the ␤-subunits of Hex A and Hex B; or GM2A, which encodes the monomeric G M2 activator protein. Therefore, there are 3 main forms of G M2 -gangliosidosis: Tay-Sachs disease (B variant; McKusick 272800) and related variants, resulting from mutations of the HEXA gene, are associated with deficient activity of Hex A but normal Hex B; Sandhoff disease (0 variant; McKusick 268800) and related variants, resulting from mutations of the HEXB gene, are associated with deficient activity of both Hex A and Hex B; and G M2 activator protein deficiency (AB variant; McKusick 272750), due to mutations of the GM2A gene, is characterized by normal Hex A and Hex B but an inability to form a functional complex of G M2 -ganglioside and G M2 activator protein. There are also pseudodeficient or clinically benign disorders (Hex Aminus pseudodeficiency) characterized by biochemical defects of Hex A but functional activity toward G M2 -ganglioside.
In animals, naturally occurring G M2 -gangliosidoses have been reported in only 3 canine breeds (German Shorthaired Pointer, 3, 9, 16, 20 Japanese Spaniel, 6 and Golden Retriever 32 ), 2 feline breeds (domestic cat 5 and Korat cat 22 ), Yorkshire pigs, 23, 24 and Muntjak deer. 8 Most of these animal models correspond to distinct human forms of G M2 -gangliosidoses: Tay-Sachs disease (Muntjak deer 8 ), Sandhoff disease (Golden Retriever 32 and 2 feline breeds 5, 22 ), and AB variant (Japanese Spaniel 13 ). The biochemical features of German Shorthaired Pointers suggest the possibility of a B1 variant that is allelic with Tay-Sachs disease. 25 In the swine disease, an accumulation of G M2 -ganglioside is associated with elevated Hex activity in serum and reduced Hex activity in tissues, 23, 24 suggesting that excessive efflux of Hex from tissues to the serum may produce an intracellular enzyme deficiency. In addition, 2 mutations of the feline HEXB gene have been identified and shown to be responsible for feline Sandhoff disease. 1, 21 These animal models are genetically determined diseases of potential value as experimental models that can be used to study various problems pertaining to human G M2 -gangliosidoses.
This article describes laboratory techniques for diagnosis of canine G M2 -gangliosidosis using blood and cerebrospinal fluid (CSF), which can be collected with minimal invasiveness from living individuals. The use of these methods made it possible to make the first reported identification of canine Sandhoff disease. 32 
Materials and methods
Animals and preparation of samples. Blood and CSF were obtained from a 15-mo-old male Golden Retriever with Sandhoff disease 32 and 22 clinically healthy Beagles (1-12 yr of age). Leukocytes were isolated from heparinized venous blood by a differential sedimentation procedure using 4% dextran (molecular weight [MW] 180,000-200,000) a in physiological saline. 27 Leukocyte pellets, serum, and CSF were frozen at Ϫ80 C until use.
Assay of Hex. Leukocytes were homogenized by sonication in deionized water to yield 0.5 mg/ml protein. 4 The Hex activity of leukocyte homogenates, serum, and CSF was measured spectrofluorometrically using 4-methylumbelliferyl N-acetyl-␤-D-glucosaminide (4-MUGlcNAc) b as a substrate. 28 Both heated (50 C for 3 hr at pH 4.5) and unheated enzyme sources were incubated with the substrate (2 mM) in 0.1 M citrate-phosphate buffer (pH 4.5) for 1 hr at 37 C, and the concentration of liberated 4-methylumbelliferone was determined using a spectrofluorometer. c The activity of the unheated sample gave the total Hex activity and the heated sample that of Hex B. The activity of Hex A was calculated by determining the difference between these. In addition, the total Hex activity was also measured using 4-methylumbelliferyl 7-(6-sulfo-2-acetamido-2-deoxy-␤-D-glucopyranoside) (4-MUGlcNAc-6S), b which is a specific fluorogenic substrate for Hex A. 2, 18 Analysis of Hex by electrophoresis. Leukocyte lysates were prepared by sonication and centrifugation to yield 10 mg/ml protein. 4 Electrophoresis of both heated (50 C for 3 hr) and unheated lysates was carried out at pH 6.2 in 0.02 M citrate-phosphate buffer on cellulose acetate membranes d according to the method reported previously. 31 Two-microliter aliquots of the lysates were applied to the membrane, and the membrane was subjected to electrophoresis for 90 min at 0.4 mA per centimeter width of the membrane and 100 V. After electrophoresis, the membrane was incubated at 37 C for 60 min between 2 filter papers impregnated with substrate solution (2 mM 4-MUGlcNAc in 0.1 M citrate-phosphate buffer, pH 4.5). After incubation, the membrane was illuminated with ultraviolet light (312 nm), and the bands of Hex activity were immediately photographed.
Analysis of G M2 -ganglioside. Thin-layer chromatography (TLC)/enzyme-immunostaining for G M2 -ganglioside in CSF was performed according to the method for the gangliotetraose series gangliosides that was reported previously, 14 with some alterations for the analysis of G M2 -ganglioside. Cerebrospinal fluid (500 l) was thawed, and CSF gangliosides were extracted 3 times using organic solvents, each time with a chloroform-methanol mixture, comprising a 2-ml (2:1, vol/ vol) upper phase, 1.5 ml methanol supernatant, and 2 ml (1:2, vol/vol) supernatant. The combined lipid extract was evaporated in vacuo, dissolved in approximately 700 l of deionized water, and then dialyzed using a cellulose ester membrane (MW cutoff 500) e against a sufficient volume of deionized water at 4 C for 2 days. After dialysis, the solution was collected and evaporated in vacuo and then dissolved in chloroform-methanol (2:1, vol/vol). The clear supernatant was evaporated in vacuo and redissolved in 100 l of chloroform-methanol (2:1, vol/vol).
A sample of the ganglioside fraction (20 l), which corresponded to 100 l of CSF, was applied to a TLC plate, f and then the plate was developed with chloroform-methanol-12 mM MgCl 2 -15 M NH 4 OH (60:40: 7.5:3, vol/vol/vol/vol). After the plate was dried while blowing warm air on it, it was again developed with chloroform-methanol-12 mM MgCl 2 (58:40:9, vol/ vol/vol) in the same direction and then dried. The plate was soaked in solution A (10 mM phosphate-buffered saline [ PBS; pH 7.4] containing 1% egg albumin a and 1% polyvinylpyrrolidone [K-30, MW 40,000] a ) at room temperature for 30 min after it was developed with solution A diluted 10-fold with PBS in the same direction as the first 2 times.
The TLC plate then was subjected to the following immunostaining procedure. The plate was treated with mouse anti-G M2 -ganglioside antibody (Ig M) g in solution A (1:500 dilution ratio) at 37 C overnight. After the first reaction, the plate was washed with 10 mM PBS containing 0.1% Tween 20 h and soaked in solution A at 37 C for 15 min. The plate then was treated with horseradish peroxidase-conjugated goat antimouse Ig M antibody i in 10 mM PBS containing 3% 
* The values of total and isoenzyme B activities in leukocytes and serum were reported previously. 32 † Mean Ϯ SD. polyvinylpyrrolidone (1:500 dilution ratio) at 37 C for 2 hr and washed with 10 mM PBS. The band of G M2 -ganglioside was observed by a peroxidase reaction involving 4-chloro-1-naphthol a as a chromogenic substrate. Purified G M2 -ganglioside, j which was quantitatively determined by the method reported previously, 15 was used as a standard for densitometric scanning. k
Results

Activity of Hex.
The Hex activity in leukocytes, serum, and CSF, which was measured using 4-MUG1cNAc as a substrate, is shown in Table 1 . In normal dogs, Hex activity was detected in not only leukocytes and serum but also CSF. The activities of total Hex and isoenzymes A and B were markedly reduced in leukocytes, serum, and CSF in a dog with Sandhoff disease, compared with those in normal dogs. Normal canine Hex activities measured using 4-MUG1cNAc-6S as a substrate were lower than normal values measured using 4-MUG1cNAc in leukocytes and serum, and no activity was detectable in the CSF using 4-MUG1cNAc-6S ( Table 2 ). The activities in leukocytes and serum were also markedly reduced in a dog with Sandhoff disease compared with those in normal dogs when using 4-MUG1cNAc-6S.
Electrophoresis of Hex. Electrophoresis on a cellulose acetate membrane of a leukocyte lysate from a normal dog showed that the 2 major isoenzymes, Hex A and Hex B, were not separated distinctively but instead were detected as a broad band (Fig. 1) . Only a band of Hex B was present in normal leukocyte lysate heated at 50 C for 3 hours, in which Hex A was inactivated. On the other hand, electrophoresis of a lysate from a dog with Sandhoff disease showed no fluorescent bands.
G M2 -ganglioside in CSF. G M2 -ganglioside in CSF in a normal dog and in a dog with Sandhoff disease was detected using the TLC/enzyme-immunostaining method (Fig. 2) . The G M2 -ganglioside band in the dog with Sandhoff disease was much denser than that in the normal dog. In this method, the concentration of G M2 -ganglioside in CSF is determined by densitometric scanning on the basis of standards of G M2 -ganglioside. In the previous report by Yamato et al., 32 G M2 -ganglioside in the affected dog's CSF was markedly increased to 68.7 nmol/liter, which was 46 times the normal value (1.5 Ϯ 0.8 nmol/liter, mean Ϯ SD, n ϭ 5).
Discussion
Like most lysosomal glycosidases, Hex hydrolyzes a broad spectrum of substrates. 10 They are specific for only the terminal nonreducing sugar: the ␤-linkage of the N-acetyl-␤-D-glucosaminide (GlcNAc) or N-acetyl-␤-D-galactosaminide (GalNAc). The most sensitive and commonly used synthetic substrate is the GlcNAc derivative of the fluorogenic compound 4-MUGlcNAc. It is recognized by both Hex A and Hex B and does not require G M2 activator protein for activity. On the other hand, 4-MUGlcNAc-6S is specific for ␣-subunit catalytic sites of Hex A and Hex S. In the present study, normal canine leukocytes, serum, and CSF had Hex activities toward 4-MUGlcNAc, and normal canine leukocytes and serum had Hex activities toward 4-MUGlcNAc-6S. The Hex activities in a dog with Sandhoff disease were markedly reduced in all the enzyme sources, although the slight residual activities of total Hex and the calculated level of isoenzyme A may have been due to intact Hex S, a dimer of the ␣-subunit. These results suggest that both of the artificial substrates were useful for the diagnosis of canine G M2 -gangliosidosis. Furthermore, 4-MUGlcNAc had the following advantages for the diagnosis of Sandhoff disease: it lacked specificity for a particular isoenzyme, and it revealed higher activity in normal specimens than 4-MUGlcNAc-6S.
In humans, patients with the AB variant show normal or elevated activities of all the Hex isoenzymes. 10 Furthermore, Hex A in patients with the B1 variant behaves like normal Hex A in some respects, such as isoelectric point, heat stability, and activity toward 4-MUGlcNAc, but is inactive toward the physiological substrate G M2 -ganglioside and also toward the sulfated synthetic substrate 4-MUGlcNAc-6S. In dogs, Japanese Spaniels with the AB variant show markedly elevated total Hex activity toward 4-MUGlcNAc 6 and pnitrophenyl (PNP) derivatives (PNPGlcNAc and PNPGalNAc). 13 German Shorthaired Pointers, which may be similar to humans with the B1 variant, show normal Hex activity toward 4-MUGlcNAc 25 and elevated activity toward PNP derivatives, 9 whereas the activity toward 4-MUGlcNAc-6S is reduced, similar to patients with the human B1 variant. 7 Therefore, Hex activities should be measured using at least 4-MUGlcNAc and 4-MUGlcNAc-6S to identify novel canine G M2 -gangliosidosis. In addition, both cell (leukocyte) and fluid (serum and CSF) samples should be used for the determination of Hex activity to identify atypical forms such as G M2 -gangliosidosis in Yorkshire pigs, in which the Hex activity is reduced in cells and elevated in the serum. 17, 23 Electrophoresis on cellulose acetate membranes or gels has been used for the diagnosis of human and feline G M2 -gangliosidosis. 5, 12, 29 Hex A and Hex B in humans and cats can be clearly separated on cellulose acetate membranes or gels. Therefore, this method is useful for the diagnosis of Tay-Sachs and Sandhoff diseases, but AB and B1 variants cannot be diagnosed by this method because they possess normal or elevated Hex activities. In the present study, cellulose acetate membrane electrophoresis demonstrated a deficiency of the total Hex activity in a dog with Sandhoff disease. However, normal canine Hex A and Hex B were not separated thereby, although the positions of the 2 major isoenzymes could be identified on cellulose acetate membranes based on the mobility of Hex B in a heated leukocyte lysate. The isoenzyme profile of canine Hex in cellulose acetate gel electrophoresis has not yet been well defined, and Hex from canine Diagnosis of canine G M2 -gangliosidosis brain shows 1 diffuse band, similar to the result seen in the present study. 13 Therefore, this method cannot be applied for the diagnosis of AB and B1 variants in canine G M2 -gangliosidosis or the equivalent of TaySachs disease in dogs.
Analysis of Hex cannot necessarily be used to make an unequivocal diagnosis of G M2 -gangliosidosis because patients with AB and B1 variants show normal or elevated Hex activities and individuals with Hex Aminus pseudodeficiency have defects of Hex A but functional activity toward G M2 -ganglioside. 10 For a definite diagnosis of G M2 -gangliosidosis, the accumulation of G M2 -ganglioside should be demonstrated in the central nervous system in individuals manifesting clinical symptoms. Therefore, the disease is diagnosed by postmortem examination in most cases, especially in domestic animals.
In the present study, G M2 -ganglioside could be detected in the CSF and determined quantitatively in as little as 100 l of CSF using the TLC/enzyme-immunostaining method. An increased level of G M2 -ganglioside in the CSF detected by this method strongly suggested an accumulation of G M2 -ganglioside in the central nervous system. In addition, using this method, early diagnosis can be made using samples obtained from living animals, resulting in a quick determination of the prognosis of the affected animals. However, further studies will be required to determine the relationship between the accumulation of G M2 -ganglioside in the central nervous system and an increased level of G M2 -ganglioside in the CSF. This method would be even more useful if the clinical stage of the disease in which it can be applied were determined.
In conclusion, the laboratory techniques used in the present study were shown to be useful for diagnosis of canine G M2 -gangliosidosis. These techniques enable definitive and early diagnosis of canine G M2 -gangliosidosis even if tissues and organs cannot be obtained. These methods may be useful in other mammalian species in addition to dogs. 
